Literature DB >> 16902892

Cardiac surgery in Germany during 2005: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery.

J F Gummert1, A Funkat, A Beckmann, K Hekmat, M Ernst, A Krian.   

Abstract

All cardiac surgical procedures performed in 79 German cardiac surgical units throughout the year 2005 are presented in this report, based on a voluntary registry, which is organized by the German Society for Thoracic and Cardiovascular Surgery. In 2005, a total of 98 860 cardiac surgical procedures (ICD and pacemaker procedures excluded) were collected in this registry. More than 8.4 % of the patients were older than 80 years, compared to 7.8 % in 2004. Hospital mortality in 54 126 isolated CABG procedures (9.7 % off-pump) was 2.9 %, while a mortality of 4.5 % was observed in 19 203 isolated valve procedures. This registry is an important tool of the German Society for Thoracic and Cardiovascular Surgery to ensure a continuous and voluntary quality assurance and illustrate the development of cardiac surgery in Germany.

Entities:  

Mesh:

Year:  2006        PMID: 16902892     DOI: 10.1055/s-2006-924405

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  3 in total

1.  Durability of bioprosthetic cardiac valves.

Authors:  Grischa Hoffmann; Georg Lutter; Jochen Cremer
Journal:  Dtsch Arztebl Int       Date:  2008-02-22       Impact factor: 5.594

2.  EuroSCORE overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery.

Authors:  J F Gummert; A Funkat; B Osswald; A Beckmann; W Schiller; A Krian; F Beyersdorf; A Haverich; J Cremer
Journal:  Clin Res Cardiol       Date:  2009-03-05       Impact factor: 5.460

3.  Concomitant ablation of atrial fibrillation in octogenarians: an observational study.

Authors:  Herko Grubitzsch; Sven Beholz; Pascal M Dohmen; Simon Dushe; Wolfgang Konertz
Journal:  J Cardiothorac Surg       Date:  2008-04-29       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.